Skip to content

Hinge Health, Inc. HNGE Q3 2025 earnings

Reported November 4, 2025 · After market close

Revenue estimate$156.8M
EPS estimate$0.24

Next report

Aug 4, 2026 (in a month)
Revenue estimate$199.0M
EPS estimate$0.58

Financials

Q3 2025

Income statement

See full
Revenue$154.2M+53.3%
Gross profit$126.2M+59.2%
Operating income-$6.1M-58.5%
Net income-$1.8M-641%
EPS (diluted)-$0.02-300%

Balance sheet

See full
Cash & equivalents$261.3M-2.3%
Total debt$9.0M
Total equity$208.0M+145%
Total assets$769.8M

Cash flow

See full
Operating cash flow$82.4M+190%
CapEx$52.0K-83.5%
Free cash flow$82.3M+193%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$3.85B
Enterprise value$3.6B
P/S7.2×

Profitability

See full
Gross margin78.6%+5.8pp
FCF margin27.2%

Returns & leverage

See full
Debt / equity
Current ratio1.8×

Versus estimates

Ask the moment Hinge Health, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Hinge Health, Inc. report Q3 2025 earnings?
Hinge Health, Inc. (HNGE) reported Q3 2025 earnings on November 4, 2025 after market close.
What were Hinge Health, Inc.'s Q3 2025 revenue and EPS?
Hinge Health, Inc. reported revenue of $154.2M and diluted EPS of $0.34 for Q3 2025.
Did Hinge Health, Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $156.8M by $2.6M. EPS beat the consensus estimate of $0.24 by $0.10.
Where can I find Hinge Health, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-264667) and the 10-Q periodic report (0001193125-25-272353) directly on SEC EDGAR. The filing index links above go to sec.gov.